Brief: Cue Biopharma CEO Daniel Passeri To Serve As Interim CFO
10/06/2025 21:03
June 10 (Reuters) - Cue Biopharma Inc CUE.O: CUE BIOPHARMA INC - CEO DANIEL PASSERI TO SERVE AS INTERIM CFO - SEC FILING CUE BIOPHARMA INC - KERRI-ANN MILLAR RESIGNS AS CFO - SEC FILING Source text: [ID:n0000950170-25-084279] Further company coverage: CUE.O (((( Reuters.briefs@thomsonreuters.com ;));))
Recent news on Cue Biopharma
See all newsU.S. STOCKS ON THE MOVE-Insmed, Marvell, Meta
US STOCKS ON THE MOVE-Meta, Marvell Technology, Insmed
U.S. STOCKS ON THE MOVE-Accenture, Arhaus, Alkermes
Cue Biopharma surges after positive results from mid-stage study for CUE-221
Brief: Cue Biopharma Announces Positive Topline Results From Cue-221 Phase 2 Study In Chronic Spontaneous Urticaria